P. Kiely

发表

No evidence of a significantly increased risk of transfusion‐transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12‐month deferral for men who have had sex with men (CME)

A. Keller, C. Seed, M. Law, 2010, Transfusion.

Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment

V. Hoad, R. Flower, C. Seed, 2017, Vox sanguinis.

Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review

V. Hoad, I. Gosbell, C. Seed, 2022, Transfusion Medicine and Hemotherapy.

An Outbreak of Japanese Encephalitis Virus in Australia; What Is the Risk to Blood Safety?

V. Hoad, E. Viennet, I. Gosbell, 2022, Viruses.

An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories

W. Dimech, B. Francis, E. Dax, 2009, Vox sanguinis.

Risk of variant Creutzfeldt–Jakob disease transmission by blood transfusion in Australia

Hong Yang, J. Kaldor, V. Hoad, 2022, Vox sanguinis.

Analysis of sample‐to‐cutoff ratios on chemiluminescent immunoassays used for blood donor screening highlights the need for serologic confirmatory testing

P. Kiely, S. Parker, A. Cheng, 2010, Transfusion.

Modeling the West Nile virus transfusion transmission risk in a nonoutbreak country associated with traveling donors

E. Wood, M. Gambhir, Z. McQuilten, 2020, Transfusion.

Refining the risk estimate for transfusion‐transmission of occult hepatitis B virus

V. Hoad, A. Keller, C. Seed, 2017, Vox sanguinis.

A method for estimating the residual risk of transfusion‐transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti‐HBc screening

C. Seed, P. Kiely, 2013, Vox sanguinis.

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT

A. Keller, C. Seed, T. Cobain, 2002, Transfusion.

Blood safety assessment of hepatitis A outbreak linked to frozen pomegranate arils: are foodborne outbreaks an emerging blood safety risk?

V. Hoad, I. Gosbell, C. Seed, 2019, Transfusion.

The potential complexity and need for caution when interpreting atypical human immunodeficiency virus reactivity in blood donors.

D. Spelman, M. Catton, D. Chibo, 2015, Blood transfusion = Trasfusione del sangue.

Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus

A. Keller, C. Seed, P. Kiely, 2005, Internal medicine journal.

Understanding occult hepatitis C infection

H. Chan, R. Flower, M. Dean, 2020, Transfusion.

Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk

E. Wood, M. Gambhir, Z. McQuilten, 2017, Transfusion Medicine Reviews.

Severe acute respiratory syndrome coronavirus‐2: implications for blood safety and sufficiency

V. Hoad, I. Gosbell, C. Seed, 2020, Vox sanguinis.

The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world

H. Kelly, D. Siebert, R. Hammond, 2000, Epidemiology and Infection.

False positive viral marker results in blood donors and their unintended consequences

E. Wood, V. Hoad, P. Kiely, 2018, Vox sanguinis.

Can we improve the management of blood donors with nonspecific reactivity in viral screening and confirmatory assays?

E. Wood, P. Kiely, 2005, Transfusion medicine reviews.

Analysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor management

P. Kiely, Y. Stewart, L. Castro, 2003, Transfusion.

Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection

C. Seed, P. Kiely, A. Margaritis, 2014, Transfusion.

The significance of third‐generation HCV RIBA‐indeterminate, RNA‐negative results in voluntary blood donors screened with sequential third‐generation immunoassays

P. Kiely, S. Parker, D. Kay, 2004, Transfusion.

International forum on Occult hepatitis B infection and transfusion safety

P. Gallian, L. Jarvis, S. Sauleda, 2019, Vox sanguinis.

Infectivity of blood components from donors with occult hepatitis B infection – results from an Australian lookback programme

B. Bell, A. Keller, C. Seed, 2015, Vox sanguinis.

Emerging infectious disease agents and blood safety in Australia: spotlight on Zika virus

E. Wood, M. Gambhir, A. Cheng, 2017, The Medical journal of Australia.

Mpox outbreak in 2022: implications for blood component and donor human milk safety in Australia

V. Hoad, I. Gosbell, P. Kiely, 2023, The Medical journal of Australia.

Anti‐HCV confirmatory testing of voluntary blood donors: comparison of the sensitivity of two immunoblot assays

P. Kiely, D. Jardine, Leo A. Eliades, 2002, Transfusion.

Anti‐HCV immunoblot indeterminate results in blood donors: non‐specific reactivity or past exposure to HCV?

P. Kiely, C. Styles, 2017, Vox sanguinis.

Results of HCV screening of volunteer blood donors with a chemiluminescent immunoassay and a second‐ or third‐generation EIA: overlap of false‐positive reactivity and its impact on donor management

P. Kiely, D. Wilson, 2000, Transfusion.

Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays

C. Seed, P. Kiely, A. Margaritis, 2003, Transfusion.

West Nile virus transfusion‐transmission risk in Australia associated with a seasonal outbreak in the United States

E. Wood, M. Gambhir, Z. McQuilten, 2022, Transfusion.

Erratum to “Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk” (Transfusion Medicine Reviews 31/3 [2017] 154-164)

E. Wood, M. Gambhir, Z. McQuilten, 2017, Transfusion Medicine Reviews.

Re‐evaluating the residual risk of transfusion‐transmitted Ross River virus infection

V. Hoad, A. Keller, C. Seed, 2016, Vox sanguinis.

Assessing infectious threats – trick or threat?

C. Seed, P. Kiely, 2015 .

Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA

A. Keller, C. Seed, P. Kiely, 2007, Transfusion.

The risk of dengue transmission by blood during a 2004 outbreak in Cairns, Australia

A. Keller, C. Hyland, Anthony J Keller, 2009, Transfusion.

Long‐term serologic follow‐up of blood donors with biologic false reactivity on an anti‐human T‐cell lymphotropic virus Types I and II chemiluminescent immunoassay and implications for donor management

P. Kiely, M. Kebede, B. Thomas, 2008, Transfusion.

Unusually strong, but transient, nonspecific human immunodeficiency virus types 1 and 2 antibody reactivity

P. Kiely, M. Kebede, K. Miller, 2008, Transfusion.

International Forum on Occult hepatitis B infection and transfusion safety

P. Gallian, L. Jarvis, S. Sauleda, 2019, Vox sanguinis.

Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria

J. Hocking, G. Cooper, N. Crofts, 1997, Journal of viral hepatitis.

Confirming transfusion‐transmitted viral infections in the molecular age: time to get back to the basic definition of infection for hemovigilance

V. Hoad, I. Gosbell, C. Seed, 2019, Transfusion.

Recently Acquired Blood-borne Virus Infections in Australian Deceased Organ Donors: Estimation of the Residual Risk of Unexpected Transmission

H. Opdam, J. Knott, C. Seed, 2023, Transplantation direct.

Comment on White paper on pandemic preparedness in the blood supply

V. Hoad, I. Gosbell, C. Seed, 2023, Vox sanguinis.

Endoscopies, blood‐borne viruses and blood donors: time to move on from precaution

V. Hoad, C. Seed, P. Kiely, 2020, Vox sanguinis.